On June 5th, GeLongHui reported that Janus Matsumoto (02161.HK) has released a notice that a board meeting is scheduled for June 18, 2024 (Tuesday) to consider and approve the annual performance of the company and its subsidiary by March 31, 2024 and to consider recommending the distribution of final dividends (if any), as well as handling other matters.
健倍苗苗(02161.HK)拟6月18日举行董事会会议批准全年业绩
Jun 18, GenScript Biotech Corporation (02161.HK) will hold a board of directors meeting to approve the full-year performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.